3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
8
Stomach Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Microsatellite Stable Rectal Carcinoma
1
Melanoma
1
Lymphoma
1
Hemangiosarcoma
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
60
Cisplatin
43
Cetuximab
25
Carboplatin
24
Paclitaxel
19
Radiotherapy, Intensity-Modulated
18
Magnetic Resonance Spectroscopy
18
Nivolumab
17
Radiotherapy
16
Specimen Handling
14
Docetaxel
13
Platinum
12
1,2-diaminocyclohexaneplatinum II citrate
11
Taxes
8
Fluorouracil
8
Biopsy
7
atezolizumab
6
Radiation
6
(225)Ac-DOTA-c(RGDyK)
6
dostarlimab
5
cemiplimab
5
Ipilimumab
5
Standard of Care
4
Immunoglobulin G
4
Disulfides
4
Cyclophosphamide
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
toripalimab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
balstilimab
×
90 days
×
Clear all
No trials found.